Company > Governance > Management



organigramme carmat mai 2015 web

Professor Alain CARPENTIER, Honorary Scientific Director


Professor emeritus at the Descartes University of Paris and "adjunct" professeur au Mount Sinai Medical School à New York, Alain Carpentier has made decisive contributions to the surgery of heart valves and heart failure. He is considered by the international community as the father of modern valve surgery: each year worldwide, approximately 250 000 patients with valve disease are treated with methods and techniques from his research. Breaking with the traditional use of mechanical prostheses that require heavy anticoagulant therapy, this work has resulted in biological heart valve replacement and reduced complications. Grand Prize winner of the Foundation for Medical Research (1998) in 2007 he received the prestigious Albert Lasker Medical Research, which crowns his invention of bioprostheses and the development of techniques for reconstructive surgery of heart valves. Professor Carpentier was elected President of the Academy of Sciences for 2011-2012.

Marcello CONVITI, Director General


Marcello Conviti speaks five languages, and he has an MBA from the University of Turin and a PhD in IT technologies from the University of Pisa. Marcello CONVITI began his career in Italy with IBM in 1978. After a few years working for renowned Italian companies, including Fiat, he focussed on European positions within the life sciences industry. For 12 years he held several strategic positions in SORIN BIOMEDICA, an Italian company that designs cardiac medical devices. Before joining CARMAT, Marcello Conviti held several senior international positions with Edwards Lifesciences during a period of 17 years (most recently Senior Vice President for Strategy and New Business Development).
Edwards Lifesciences is the world leader in heart valves, including its flagship product, the Edwards-Carpentier heart valve, which revolutionised cardiac surgery. Marcello Conviti is also a member of the Board of Directors at EUCOMED, the European confederation of associations of manufacturers of medical devices.

Patrick COULOMBIER, Chief Operating Officer

manage_coulombier_bisPatrick Coulombier has headed the project team for the CARMAT total artificial heart within the Eads Group since July 2001. Before that he worked for Mbda France as director of two international programmes in the area of defence, one concerning a British air combat training system and the other relating to a Franco-German drone system. Between 1978 and 1990, before joining MBDA France, Patrick Coulombier had a number of different research and development posts in connection with a range of aeronautic and space projects at Thales avionnique (Airbus A130, A320, Rafale Combat Aircraft, Super Puma Helicopter and the Hermes Spacecraft). Patrick Coulombier has a degree in electronic engineering.

Petrus JANSEN, Medical Director

manage_jansen_bisPetrus Jansen began his career in 1997 in the Netherlands with Edwards Lifesciences as Head of Research and Clinical Trials, particularly in connection with the Novacor programme (left ventricular assistance device). Petrus Jansen then held similar positions in Europe and the United States with Jarvik Heart in charge of clinical trials and obtaining the CE Conformity Marking for its products. Before joining CARMAT in December 2009, Petrus Jansen was the Medical Director at World Heart USA for five years. Petrus Jansen qualified as a medical doctor from the Catholic University of Nijmegen, he has a PhD in medicine from the University of Amsterdam, and he was research fellow at the University of Rotterdam.